- Home
- VRAX vs VEEE Comparison
VRAX vs VEEE Comparison
Compare VRAX & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- VEEE
- Stock Information
- Founded
- VRAX 2013
- VEEE 1994
- Country
- VRAX United Kingdom
- VEEE United States
- Employees
- VRAX N/A
- VEEE N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- VEEE Marine Transportation
- Sector
- VRAX Health Care
- VEEE Industrials
- Exchange
- VRAX Nasdaq
- VEEE Nasdaq
- Market Cap
- VRAX 5.9M
- VEEE 6.4M
- IPO Year
- VRAX 2022
- VEEE 2021
- Fundamental
- Price
- VRAX $1.09
- VEEE $0.32
- Analyst Decision
- VRAX Strong Buy
- VEEE
- Analyst Count
- VRAX 1
- VEEE 0
- Target Price
- VRAX $3.00
- VEEE N/A
- AVG Volume (30 Days)
- VRAX 125.6K
- VEEE 53.2K
- Earning Date
- VRAX 02-05-2025
- VEEE 03-20-2025
- Dividend Yield
- VRAX N/A
- VEEE N/A
- EPS Growth
- VRAX N/A
- VEEE N/A
- EPS
- VRAX N/A
- VEEE N/A
- Revenue
- VRAX $84,872.00
- VEEE $14,388,517.00
- Revenue This Year
- VRAX $5,169.18
- VEEE N/A
- Revenue Next Year
- VRAX $66.97
- VEEE N/A
- P/E Ratio
- VRAX N/A
- VEEE N/A
- Revenue Growth
- VRAX 7.03
- VEEE N/A
- 52 Week Low
- VRAX $0.60
- VEEE $0.31
- 52 Week High
- VRAX $9.00
- VEEE $0.99
- Technical
- Relative Strength Index (RSI)
- VRAX 32.51
- VEEE 36.82
- Support Level
- VRAX $1.10
- VEEE $0.32
- Resistance Level
- VRAX $1.35
- VEEE $0.42
- Average True Range (ATR)
- VRAX 0.11
- VEEE 0.02
- MACD
- VRAX 0.00
- VEEE -0.00
- Stochastic Oscillator
- VRAX 6.77
- VEEE 20.00
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.